ResearcherJiaxing UniversityActive in the last 2 years

Bin Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1235-0951; OpenAlex author ID A5045582973. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells. Co-author DOI 10.1016/j.bbrc.2026.154207 ↗
Plasma lipid levels are associated with the CD8+ T-cell infiltration and prognosis of patients with pancreatic cancer. Co-author DOI 10.1002/cam4.6080 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaofang Fan · 1 shared paper, 2026 · strength 0.28
- Paper DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells. DOI 10.1016/j.bbrc.2026.154207 ↗
Lingyu Hu · 1 shared paper, 2026 · strength 0.28
- Paper DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells. DOI 10.1016/j.bbrc.2026.154207 ↗
Jiaqi Yu · 1 shared paper, 2026 · strength 0.28
- Paper DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells. DOI 10.1016/j.bbrc.2026.154207 ↗
Xujian Chen · 1 shared paper, 2023 · strength 0.20
- Paper Plasma lipid levels are associated with the CD8+ T-cell infiltration and prognosis of patients with pancreatic cancer. DOI 10.1002/cam4.6080 ↗
Zhengxiang Zhong · 1 shared paper, 2023 · strength 0.20
- Paper Plasma lipid levels are associated with the CD8+ T-cell infiltration and prognosis of patients with pancreatic cancer. DOI 10.1002/cam4.6080 ↗
Xiaoguang Wang · 1 shared paper, 2023 · strength 0.20
- Paper Plasma lipid levels are associated with the CD8+ T-cell infiltration and prognosis of patients with pancreatic cancer. DOI 10.1002/cam4.6080 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.